Advances in asthma: New understandings of asthma's natural history, risk factors, underlying mechanisms, and clinical management.

doi:10.1016/j.jaci.2021.10.001

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Advances in asthma: New understandings of asthma's natural history, risk factors, underlying mechanisms, and clinical management.

The Journal of allergy and clinical immunology - 1 Dec 2021

Miller Rachel L, Grayson Mitchell H, Strothman Kasey

Abstract excerpt

The last 2 years yielded a proliferation of high-quality asthma research. These include new understandings of the incidence and natural history of asthma, findings on the effects of exposure to air pollution, allergens, and intake of acetaminophen, soy isoflavones, and polyunsaturated fatty acids, and exposure to microbial products. The past 2 years have benefited from great strides in determining potential...

Topics

Animals
Anti-Asthmatic Agents
Asthma
Biological Products
Biomarkers
Desensitization, Immunologic
Humans
Immunity, Innate
Microbiota
Phenotype
Risk Factors
T-Lymphocytes
Virus Diseases

Source

Open in PubMed

Identifiers

PMID: 34655640
DOI: 10.1016/j.jaci.2021.10.001

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics